
Daiichi Sankyo
OrganizationHeard in 3 episodes across 1 show since Sep 2026
Daiichi Sankyo is a Japanese pharmaceutical company focused on innovative medicines, particularly oncology therapies, cardiovascular treatments, and antibody-drug conjugates.
Episodes
3
across 1 show
First heard
Sep 2026
Expert statements
1
1 negative
Episodes per month
Public PodLume episodes featuring it, over the last year.
2
1
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 2 |
| Oct 2026 | 0 |
| Nov 2026 | 1 |
Email alert
Email me when Daiichi Sankyo comes up on a podcast
One email a week at most, with the new episodes that mention Daiichi Sankyo. Free, no account needed, unsubscribe in one click.
What experts have said about Daiichi Sankyo
1 statement · 1 negative
Daiichi Sankyo shares are down 2.5%
“Daiichi Sankyo in Japan is down 2.5%”
Open the episode · Lenovo Falls, BHP Down, Daiichi DipsListen at 4:21
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
3 episodes featuring Daiichi Sankyo, newest first